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Last but not least, I would like to thank my husband and my family who love, support and encouragement enabled me to accomplish this work. Upon exposure to low oxygen tension the mutant hemoglobin S becomes less soluble and aggregates into large polymers. This results in a distorted erythrocyte with marked decrease in its deformability contributing to the vaso-occlusive and haemolytic aspects of the disease (Embury, 2000).
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Sickle cell disease is characterized by an increased susceptibility to infections and vaso-occlusive complications. Patients with SCD can develop specific and sometimes life-threatening complications as well as extensive organ damage reducing both their quality of life and their life expectancy (Schhnog et al .
, 2004).
It is an inherited condition of universal distribution and its most common clinical manifestations is anemia due to chronic hemolysis .persistant and accelerated hemolysis associated with multiple transfusions is a recognized risk factor for development of cholethiasis. The occurrence of gallstones is one of the most important manifestation of SCD in the digestive tract (Gumiero et al.
, 2008).
Liver is one of the organs involved in the multiorgan failure that occur in SCD. 
Aim of the work
The objective of this work is to describe the clinical, laboratory, ultrasonographic abnormalities of the hepatobiliary system among Egyptian SCD patients.
Chapter 1 Sickle Cell Anemia
It is a collective term for a group of genetic disorders characterized by the predominance of hemoglobin S (Hb S) which is the result of a single base pair change, thymine for adenine, at the 6th codon of the β-globin gene. These disorders include sickle cell anemia (SS), the sickle beta thalassemia syndromes (S β+ or S β0), and hemoglobinopathies in which Hb S is present in combination with another variant hemoglobin.as hemoglobin SC disease, hemoglobin SD disease, and hemoglobin SE disease (Barlow, 2007).
Definition:
Sickle cell anemia (SCA) is a genetic (inherited) disease that occurs when both β-globin genes have the sickle cell mutation, homozygous Hb S. One of the basic events in SCA is the polymerization of HbS inside the red blood cells, which occurs upon deoxygenation of hemoglobin. This ultimately distorts the erythrocyte membrane and creates a rigid 'sickled' red cell (Nagel et al, 2007). Noel was readmitted several times over the next three years for "muscular rheumatism" and "bilious attacks". Noel completed his studies and returned to the capital of Grenada (St. George's) to practice dentistry. He died of pneumonia in 1916 and was buried in the Catholic cemetery at Sauteurs in the north of Grenada (Savitt, 1989).
The disease was named "sickle-cell anaemia" by Vernon Mason in 1922. However, some elements of the disease had been recognized earlier: A paper in the Southern Journal of Medical Pharmacology in 1846 described the absence of a spleen in the autopsy of a runaway slave. The African medical literature reported this condition in the 1870s, when it was known locally as ogbanjes ("children who come and go") because of the very high infant mortality rate caused by this condition. A history of the condition tracked reports back to 1670 in one Ghanaian family (Dhanani H, 2004).
Mode of inheritance:
SCD is an autosomal recessive disorder with gene map locus 11p15.5.At least five different haplotypes are linked to the sickle gene, each of which can be identified based on mutation analysis in the promoter sequences of the ɤ-gamma and α-gamma globin genes. These haplotypes are named following the geographical locations where they most occur. Namely, the Arabia-Indian haplotype is characterized by significantly higher levels of fetal hemoglobin (HbF) levels and a milder course of the disease. In contrast, patients with the African haplotypes, Bantu and Benin, express relatively lower levels of HbF with severe clinical presentations (Tadmouri et al., 2006).
Epidemiology:
No sex predilection exists, since SCA is not an X-linked disease (Bergeron et al., 2004) . Each year about 300, 000 infants are born with major hemoglobin disorders including more than 200 000 cases of SCA in Africa (WHO, 2006) .
SCA is particularly common among people whose ancestors come from sub-Saharan Africa, India, Saudi Arabia, and Mediterranean countries. The prevalence of the sickle-cell trait ranges between 10% and 40% across equatorial Africa and decreases to between 1% and 2% on the north African coast and <1% in South Africa (WHO, 2006).
This geographical distribution has probably arisen because sickle cell trait offers some protection against malaria, as sickle cell trait have an increased resistance to fatal malaria (Aidoo et al., 2002).
physiology: o Path Molecular pathogenesis
SCA results from an A to T transversion at the sixth codon of the hemoglobin beta globin gene on chromosome 11p15.5. The mutation of a single DNA base leads to the substitution of a valine for a glutamic acid in the beta globin polypeptide of sickle hemoglobin (HbS). Deoxygenation of the heme moiety of HbS leads to dock of valine with complementary sites on adjacent globin chains (hydrophobic interactions) leading to aggregate of HbS molecules into larger polymers. The polymerization is dependent on intra-erythrocytic HbS concentration; degree of cell deoxygenation, pH, and the intracellular concentration of HbF. Inhibition of HbS polymerization by HbF requires the formation of asymmetrical HbS/ HbF hybrid forms (α 2 δβ s ). Polymerization tendencies of mixtures of HbS and several Hb variants show that residues 22, 80, and especially 87 of the γ chain are implicated in intermolecular contact sites that stabilize the deoxygenated-HbS polymers. The polymer is a rope-like fiber that aligns with others to form a bundle, distorting the red cell into classic crescent or sickled forms. These shapes interfere with a critical erythrocyte feature; its deformability (Stuart et al., 2004 ).
Basic pathophysiology of vaso-occlusion
The polymerization of HbS is a nucleation-initiated reaction with a delay time, during which no polymer is detectable. At the end of this period, the critical nucleus is formed, and exponential polymer formation follows. The inherent instability of the HbS polymer leads to oxidative damage (o2-) of the red membrane in which phosphatidylserine (PS) becomes exposed on the outer surface of the membrane, which activates the coagulation system and leads to the efflux of K and Cl. To compensate for the loss of K and Cl, water exits the cell and the cell becomes more acidic (influx of H Cl). Acidosis then activates the K-Cl cotransporter (K:Cl), thereby leading to further efflux of K and Cl and more dehydration and intracellular acidosis.
Some intravascular hemolysis occurs because of red blood cell membrane damage, which leads to free hemoglobin tetramer binding to plasma nitric oxide (NO). depletion of plasma NO, endothelin-1, and eicosanoid dysregulation leads to vasoconstriction, which along with increased RBC rigidity and increased adherence of sickles RBCs to vessel walls, leads to decrease blood flow, hypoxia and vascular injury and localized damage to endothelial cells. Endothelial damage leads to expression of adherent proteins on the surface of the endothelial cells, thus increasing adherence of red and white blood cells to the vessel wall. Endothelial injury and hypoxia lead to vascular injury, acute and chronic inflammation and ultimately organ damage. Each SS patient has a unique environment that can modify the severity of the disease (Heeney and Dover, 2009). Table  ( 1) demonstrating different forms of SCD. 
(Chui and Dover, 2001)
Clinical picture:
The clinical manifestations of SCD are extremely variable. Some patients are entirely asymptomatic, whereas others are constantly plagued by painful episodes. Most patients fall between these extremes and have relatively long asymptomatic periods punctuated by occasional clinical
